Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$396K Buy
9,615
+890
+10% +$34.4K 0.04% 188
2025
Q1
$364K Sell
8,725
-395
-4% -$20.6K 0.04% 195
2024
Q4
$535K Buy
9,120
+20
+0.2% +$1.18K 0.06% 162
2024
Q3
$628K Buy
9,100
+2,000
+28% +$129K 0.07% 153
2024
Q2
$453K Buy
7,100
+465
+7% +$35K 0.05% 164
2024
Q1
$623K Buy
6,635
+427
+7% +$34.4K 0.08% 139
2023
Q4
$456K Buy
6,208
+75
+1% +$4.81K 0.06% 152
2023
Q3
$382K Buy
6,133
+35
+0.6% +$2.35K 0.06% 156
2023
Q2
$451K Buy
6,098
+20
+0.3% +$1.52K 0.07% 147
2023
Q1
$479K Buy
6,078
+480
+9% +$34.6K 0.07% 139
2022
Q4
$383K Buy
5,598
+730
+15% +$46.4K 0.07% 149
2022
Q3
$258K Sell
4,868
-236
-5% -$14.1K 0.05% 164
2022
Q2
$320K Sell
5,104
-212
-4% -$13K 0.06% 157
2022
Q1
$446K Hold
5,316
0.06% 160
2021
Q4
$446K Sell
5,316
-932
-15% -$74.7K 0.06% 160
2021
Q3
$488K Buy
6,248
+1,025
+20% +$85.2K 0.07% 154
2021
Q2
$397K Buy
5,223
+510
+11% +$35.6K 0.05% 163
2021
Q1
$303K Sell
4,713
-115
-2% -$6.91K 0.05% 171
2020
Q4
$261K Buy
+4,828
New +$232K 0.04% 175

Other funds holding BRKR

Forte Capital's BRKR Position: Q2 2025 in Review

Forte Capital increased its Bruker (BRKR) stake by 10% in Q2 2025, buying an estimated $34.4K and bringing the position to 9,615 shares worth $396K. The position accounts for 0.04% of the portfolio, ranked #188.

Forte Capital first reported a position in BRKR in Q4 2020 and has held it in 19 quarters since. The position peaked at $628K in Q3 2024. 370 funds tracked by Wall St. Rank hold BRKR as of Q2 2025.

  • Forte Capital held 9,615 shares of Bruker worth $396K as of Q2 2025.
  • Forte Capital bought 890 Bruker shares in Q2 2025, an estimated $34.4K.
  • Bruker made up 0.04% of Forte Capital's portfolio in Q2 2025, its #188 holding.
  • Forte Capital first reported a position in Bruker in Q4 2020 and has held it in 19 quarters since.
  • Forte Capital's Bruker position peaked at $628K in Q3 2024.
  • 370 funds tracked by Wall St. Rank held Bruker as of Q2 2025.

Based on Forte Capital's 13F filing for Q2 2025, filed 15 Jul 2025.